• Bad Pharma: How Drug Companies Mislead Doctors and Harm Patients See large image

    Bad Pharma: How Drug Companies Mislead Doctors and Harm Patients (Paperback) By (author) Ben Goldacre

    Currently unavailable

    We can notify you when this item is back in stock

    | Add to wishlist

    OR try AbeBooks who may have this title (opens in new window).

    Try AbeBooks
    Also available in...
    Paperback $14.39
    Hardback $19.46
    CD-Audio $26.98

    Description'Bad Science' hilariously exposed the tricks that quacks and journalists use to distort science, becoming a 400,000 copy bestseller. Now Ben Goldacre puts the $600bn global pharmaceutical industry under the microscope. What he reveals is a fascinating, terrifying mess. Doctors and patients need good scientific evidence to make informed decisions. But instead, companies run bad trials on their own drugs, which distort and exaggerate the benefits by design. When these trials produce unflattering results, the data is simply buried. All of this is perfectly legal. In fact, even government regulators withhold vitally important data from the people who need it most. Doctors and patient groups have stood by too, and failed to protect us. Instead, they take money and favours, in a world so fractured that medics and nurses are now educated by the drugs industry. Patients are harmed in huge numbers. Ben Goldacre is Britain's finest writer on the science behind medicine, and 'Bad Pharma' is a clear and witty attack, showing exactly how the science has been distorted, how our systems have been broken, and how easy it would be to fix them.


Other books

Other books in this category
Showing items 1 to 11 of 11

 

Reviews | Bibliographic data
  • Full bibliographic data for Bad Pharma

    Title
    Bad Pharma
    Subtitle
    How Drug Companies Mislead Doctors and Harm Patients
    Authors and contributors
    By (author) Ben Goldacre
    Physical properties
    Format: Paperback
    Number of pages: 448
    Width: 142 mm
    Height: 213 mm
    Thickness: 32 mm
    Weight: 380 g
    Language
    English
    ISBN
    ISBN 13: 9780007509553
    ISBN 10: 0007509553
    Classifications

    BIC E4L: HEA
    Nielsen BookScan Product Class 3: T9.0
    BIC subject category V2: MB, VFD
    Warengruppen-Systematik des deutschen Buchhandels: 14620
    BISAC V2.8: SCI086000
    BIC subject category V2: KNDP
    BISAC V2.8: HEA028000
    DC23: 338.476151
    Thema V1.0: VFD, PS, KND
    Publisher
    HarperCollins Publishers
    Imprint name
    FOURTH ESTATE LTD
    Publication date
    27 September 2012
    Publication City/Country
    London
    Author Information
    Ben Goldacre is a doctor, writer, broadcaster and academic who specialises in unpicking dodgy scientific claims from drug companies, newspapers, government reports, PR people and quacks. His first book, Bad Science, reached Number One in the non-fiction charts, sold over 400,000 copies in the UK alone, and has been translated into 25 languages. He is 38 and lives in London.
    Review quote
    'Goldacre has managed to achieve something marvellous here ... He has humanised the numbers so they become relevant. More than that, this is a book to make you enraged - properly, bone-shakingly furious - because it's about how big business puts profits over patient welfare, allows people to die because they don't want to disclose damning research evidence, and the tricks they play to make sure doctors do not have all the evidence when it comes to appraising whether a drug really works or not. A work of brilliance.' Max Pemberton, Daily Telegraph 'This is an important book. Ben Goldacre is angry, and by the time you put 'Bad Pharma' down, you should be too.' New Statesman 'What keeps you turning its pages is the accessibility of Goldacre's writing ... his genuine, indignant passion, his careful gathering of evidence and his use of stories, some of them personal, which bring the book to life.' Luisia Dilner, Guardian 'This is a book that deserves to be widely read, because anyone who does read it cannot help feeling both uncomfortable and angry.' Economist "Bad Pharma' will confirm his status as a thorn in the side of the medical Establishment - Goldacre's detailed research would be hard for any drug-company executive to contradict' Lois Rogers, Sunday Times